Co-Authors
This is a "connection" page, showing publications co-authored by Edward Mills and Craig Rayner.
Connection Strength
2.511
-
Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19. Am J Trop Med Hyg. 2020 10; 103(4):1364-1366.
Score: 0.906
-
How COVID-19 has fundamentally changed clinical research in global health. Lancet Glob Health. 2021 05; 9(5):e711-e720.
Score: 0.236
-
The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19. Am J Trop Med Hyg. 2021 Jan; 104(1):35-38.
Score: 0.230
-
The Landscape of Emerging Randomized Clinical Trial Evidence for COVID-19 Disease Stages: A Systematic Review of Global Trial Registries. Infect Drug Resist. 2020; 13:4577-4587.
Score: 0.230
-
Correction to: Early Treatment of COVID-19 Disease: A Missed Opportunity. Infect Dis Ther. 2020 Dec; 9(4):721.
Score: 0.229
-
Correction to: Early Treatment of COVID-19 Disease: A Missed Opportunity. Infect Dis Ther. 2020 Nov 09; 1.
Score: 0.228
-
Early Treatment of COVID-19 Disease: A Missed Opportunity. Infect Dis Ther. 2020 Dec; 9(4):715-720.
Score: 0.227
-
Clinical trials of disease stages in COVID 19: complicated and often misinterpreted. Lancet Glob Health. 2020 10; 8(10):e1249-e1250.
Score: 0.225